Omega Therapeutics (OMGA) Appoints Chris Schade to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Omega Therapeutics (OMGA) Appoints Chris Schade to its Board

Omega Therapeutics Appoints Chris Schade to its Board of Directors

July 12, 2023 7:00 AM EDT

CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (Omega), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced the appointment of Chris Schade to its Board of Directors. Mr. Schade brings over 30 years of experience across the biopharma industry to support the Companys long-term growth objectives.

We are thrilled to welcome Chris to Omegas Board of Directors as we advance our pipeline through key milestones in 2023 and beyond, said Noubar Afeyan, Omega co-founder and Chairman of the Board. His... More